Context Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move
Context Therapeutics stock fell after hours as Q2 loss widened and the company prioritized its pipeline.
Context Therapeutics lost more money in the last three months and is spending a lot on new medicines still being tested. When a company's losses grow, people sometimes sell, but you can watch whether their test medicines are progressing—that's what matters most for their future.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.